Versant Capital Management, Inc Amphastar Pharmaceuticals, Inc. Transaction History
Versant Capital Management, Inc
- $710 Million
- Q3 2025
A detailed history of Versant Capital Management, Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 291 shares of AMPH stock, worth $7,176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
291
Previous 624
53.37%
Holding current value
$7,176
Previous $14,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding AMPH
# of Institutions
261Shares Held
32.9MCall Options Held
18.3KPut Options Held
13K-
Black Rock Inc. New York, NY5.94MShares$147 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$66.3 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$50.2 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$40.1 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$38.9 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.21B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...